Answers are grounded in this paper and cite their sources.
Obesity is intricately associated with type-2 diabetes (T2D) and other cardiovascular conditions, increasing morbidity, mortality, and health care costs. Metabolic and bariatric surgeries (MBS) have shown promising results in significant weight loss and T2D remission, but existing predictive scores for post-MBS diabetes remission do not consider insulin dosage, potentially overlooking a critical factor.
No takes yet. Share an insight, caveat, or question.
Ghusn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: